All In Biotech

Drug Trial Radar · NCT03706261

Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults

Last checked: Nov 20, 2026Latest source record: Aug 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

145

Actual

Start

Mar 22, 2019

Primary completion

Jul 14, 2023

Study completion Jul 14, 2023

Sponsor

Lead sponsor
Adam BrickmanAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute on Aging (NIA)
First posted
Oct 15, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 35 years, up to 85 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study employs tau positron emission tomography (PET) imaging in a well-characterized multi-racial/ethnic cohort to examine the extent to which tau pathology is associated with cognition, differences in tau pathology across racial/ethnic groups, and the relationship between MRI markers of small-vessel cerebrovascular disease and tau pathology. The study also investigates amyloid-dependent tau spreading.

Conditions

  • Alzheimer Disease

Interventions

  • 18F-MK-6240Drug

    Administration of 5 mCi of 18F-MK-6240 for tau PET.

  • 18F-FlorbetabenDrug

    Administration of 8.1 mCi as a slow single intravenous bolus (6 sec/mL) in a total volume of up to 10 mL of 18F-Florbetaben for Aβ PET imaging.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Regional SUVR Value for 18F-MK-6240Time frame: 1 day
  2. Number of Participants With Amyloid Positivity (Aβ+) for 18F-FlorbetabenTime frame: 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Columbia University Irving Medical Center

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.